// App-Quantinova.ai

: IMPACT OF DIABETES MELLITUS ACROSS GENDER AND RACE ON OUTCOMES AFTER EVEROLIMUS-ELUTING STENT IMPLANTATION: FROM THE PLATINUM DIVERSITY AND THE PROMUS ELEMENT PLUS POST-APPROVAL STUDIES

Researchers

Presenter

  • Ridhima Goel

Principal Investigators

  • Bimmer Claessen

  • Paul Guedeney

  • David Kandzari

  • Melissa Aquino

  • Scott Davis

  • Luis Tami

  • John Wang

  • Islam Othman

  • Osvaldo Gigliotti

  • Amir Haghighat

  • Sarabjeet Singh

  • Mario Lopez

  • Gregory Giugliano

  • Phillip Horwitz

  • Paul Underwood

  • Dominic Allocco

  • Ian Meredith

  • Roxana Mehran

Medical Centers

  • N/A

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Endocrine/metabolic Diseases (ME)

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Diabetes

  • Venous thrombosis

Biomarkers

  • Alpha-methylacyl-CoA racemase

Drug/Treatment

  • Promus Element

  • Everolimus

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A